Apex Biologix

Apex Biologix is an FDA-registered Class II medical device manufacturer specializing in autologous biologic systems for regenerative medicine. The company's primary product portfolio includes the XCELL platform, offering Platelet-Rich Plasma (PRP), Protein Concentrate (A2M), and Bone Marrow Concentrate (BMC) systems. These platforms are engineered for precision processing and optimized biologic yield with minimal variability, targeting clinicians in orthopedic surgery, sports medicine, interventional pain management, integrative medicine (naturopathic, chiropractic, rheumatology), physical medicine & rehabilitation, aesthetic medicine (dermatology, hair restoration, sexual wellness), and podiatry. XCELL systems deliver configurable leukocyte options and customizable output volumes, with documented performance metrics including up to 10x platelet concentration over baseline and average platelet recovery of 83%. Beyond equipment, Apex Biologix provides comprehensive clinical education and training through its XCELL Learning Center (10,000 sq. ft. facility) and practice integration support. The company serves both surgical and non-surgical clinical applications and emphasizes research-backed dosing standards for orthobiologic outcomes. Operations include a corporate headquarters in Clearwater, Florida, and a Salt Lake City office serving the Mountain West region.